Biofrontera Inc. Reports Third Quarter and Nine-Month 2024 Financial Results and Provides Business Update

24 hours ago

WOBURN, Mass., Nov. 13, 2024 ( GLOBE NEWSWIRE ) -- Biofrontera Inc. ( Nasdaq: BFRI ) ( "Biofrontera" or the "Company" ) , a biopharmaceutical company specializing in the development and commercialization of photodynamic therapy ( PDT ) , today reported financial results for the three and nine ...

Ticker	Sentiment	Impact
BFRI	Somewhat Bullish	23 %